Thompson Davis & Co’s IRIDEX IRIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.7K Sell
15,444
-32,000
-67% -$34.3K 0.01% 168
2026
Q1
$47.9K Buy
47,444
+18,944
+66% +$25.8K 0.03% 137
2025
Q4
$32.5K Buy
+28,500
New +$29.3K 0.02% 148
2025
Q3
Sell
-56,726
Closed -$50K 161
2025
Q2
$50K Buy
+56,726
New +$57.8K 0.03% 123
2018
Q3
$3K Hold
500
0.01% 630
2018
Q2
$3K Hold
500
0.01% 579
2018
Q1
$3K Hold
500
0.01% 546
2017
Q4
$4K Sell
500
-150
-23% -$1.28K 0.01% 543
2017
Q3
$6K Sell
650
-625
-49% -$5.68K 0.01% 813
2017
Q2
$13K Sell
1,275
-2,150
-63% -$21.2K 0.02% 587
2017
Q1
$41K Sell
3,425
-2,875
-46% -$40.4K 0.06% 284
2016
Q4
$89K Sell
6,300
-4,400
-41% -$62.5K 0.15% 154
2016
Q3
$155K Sell
10,700
-6,850
-39% -$104K 0.27% 83
2016
Q2
$260K Buy
17,550
+14,950
+575% +$186K 0.42% 56
2016
Q1
$27K Buy
+2,600
New +$25.2K 0.04% 361
2015
Q3
Sell
-30,467
Closed -$251K 1189
2015
Q2
$251K Sell
30,467
-5,944
-16% -$55.5K 0.29% 81
2015
Q1
$389K Buy
36,411
+19,911
+121% +$193K 0.47% 35
2014
Q4
$142K Sell
16,500
-7,750
-32% -$61.4K 0.16% 130
2014
Q3
$170K Sell
24,250
-17,250
-42% -$135K 0.22% 102
2014
Q2
$341K Sell
41,500
-33,500
-45% -$288K 0.49% 49
2014
Q1
$670K Buy
75,000
+39,250
+110% +$360K 1.11% 11
2013
Q4
$364K Buy
+35,750
New +$286K 0.55% 42

Other funds holding IRIX

Thompson Davis & Co's IRIX Position: Q2 2026 in Review

Thompson Davis & Co reduced its IRIDEX (IRIX) stake by 67% in Q2 2026, selling an estimated $34.3K and leaving 15,444 shares worth $17.7K. The position accounts for 0.01% of the portfolio, ranked #168.

Thompson Davis & Co first reported a position in IRIX in Q4 2013 and has held it in 22 quarters since. The position peaked at $670K in Q1 2014. 28 funds tracked by Wall St. Rank hold IRIX as of Q2 2026.

  • Thompson Davis & Co held 15,444 shares of IRIDEX worth $17.7K as of Q2 2026.
  • Thompson Davis & Co sold 32,000 IRIDEX shares in Q2 2026, an estimated $34.3K.
  • IRIDEX made up 0.01% of Thompson Davis & Co's portfolio in Q2 2026, its #168 holding.
  • Thompson Davis & Co first reported a position in IRIDEX in Q4 2013 and has held it in 22 quarters since.
  • Thompson Davis & Co's IRIDEX position peaked at $670K in Q1 2014.
  • 28 funds tracked by Wall St. Rank held IRIDEX as of Q2 2026.

Based on Thompson Davis & Co's 13F filing for Q2 2026, filed 29 Jul 2026.